Items where Subject is "QR189.5.D53 DNA vaccines"

2015

1. Durrant, L. G., Ottensmeier, C. H., Mulatero, C., Lorigan, P., Plummer , R., Cunnell, M., Metheringham, R., Brentville, V., Machado, L., Daniels , I., Hannaman, D. and Patel, P. M. (2015) A clinical trial of a DNA vaccine (SCIB1) that targets dendritic cells in vivo in fully resected melanoma patients; a vaccine to prevent disease recurrence? Poster presented to: 15th International Conference on Progress in Vaccination Against Cancer (PIVAC-15), Tübingen, Germany, 06-08 October 2015.
2. Patel, P. M., Ottensmeier, C., Mulatero, C., Lorigan, P., Plummer, R., Hannaman, D., Cunnell, M., Metheringham, R. L., Brentville, V. A., Daniels, I., Machado, L. and Durrant, L. G. (2015) Abstract 9035: An adjuvant clinical trial of SCIB1, a DNA vaccine that targets dendritic cells in vivo, in fully resected melanoma patients. Journal of Clinical Oncology. 33(15 Sup) 0732-183X.

2014

1. Durrant, L. G., Ottensmeier, C., Lorigan, P., Mulatero, C., Plummer, R., Cunell, M., Metheringham, R. L., Brentville, V. A. and Machado, L. (2014) Abstract CT331: Phase I/II trial of a novel antibody DNA immunotherapy, targeting CD64, in the treatment of Melanoma. Cancer Research. 74(19 Sup) 0008-5472.
2. Durrant, L. G., Xue, L., Machado, L., Metheringham, R. L. and Brentville, V. A. (2014) DNA vaccines. In: Rees, R. C. (ed.) Tumor Immunology and Immunotherapy. Oxford: Oxford University Press. pp. 251-264.
3. Patel, P. M., Durrant, L. G., Ottensmeier, C., Mulatero, C., Lorigan, P., Plummer, R., Cunnell, M., Metheringham, R. L., Brentville, V. A., Machado, L., Daniels, I. and Hannaman, D. (2014) Phase I trial of ImmunoBody in melanoma patients. Poster presented to: 2014 American Society of Clinical Oncology (ASCO) Annual Meeting, McCormick Place, Chicago, Illinois, 30 May - 03 June 2014. (Unpublished)